119 related articles for article (PubMed ID: 38364233)
1. Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies.
Lau A; Blenis J; Burgos-Barragan G
Cancer Res; 2024 Apr; 84(8):1191-1194. PubMed ID: 38364233
[TBL] [Abstract][Full Text] [Related]
2. Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway.
Zhang C; Yu JJ; Yang C; Yuan ZL; Zeng H; Wang JJ; Shang S; Lv XX; Liu XT; Liu J; Xue Q; Cui B; Tan FW; Hua F
Sci Transl Med; 2023 Dec; 15(726):eade4113. PubMed ID: 38091408
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition.
Rinaldi G; Pranzini E; Van Elsen J; Broekaert D; Funk CM; Planque M; Doglioni G; Altea-Manzano P; Rossi M; Geldhof V; Teoh ST; Ross C; Hunter KW; Lunt SY; Grünewald TGP; Fendt SM
Mol Cell; 2021 Jan; 81(2):386-397.e7. PubMed ID: 33340488
[TBL] [Abstract][Full Text] [Related]
4. Identification of the Serine Biosynthesis Pathway as a Critical Component of BRAF Inhibitor Resistance of Melanoma, Pancreatic, and Non-Small Cell Lung Cancer Cells.
Ross KC; Andrews AJ; Marion CD; Yen TJ; Bhattacharjee V
Mol Cancer Ther; 2017 Aug; 16(8):1596-1609. PubMed ID: 28500236
[TBL] [Abstract][Full Text] [Related]
5. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T
Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics Analysis of the Role of PHGDH in Colon Cancer.
Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C
Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056
[No Abstract] [Full Text] [Related]
7. The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.
Krassikova L; Zhang B; Nagarajan D; Queiroz AL; Kacal M; Samakidis E; Vakifahmetoglu-Norberg H; Norberg E
Cell Death Differ; 2021 Mar; 28(3):1091-1109. PubMed ID: 33082514
[TBL] [Abstract][Full Text] [Related]
8. Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.
Song L; Smith MA; Doshi P; Sasser K; Fulp W; Altiok S; Haura EB
J Thorac Oncol; 2014 Jul; 9(7):974-982. PubMed ID: 24922005
[TBL] [Abstract][Full Text] [Related]
9. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues.
Snell K
Adv Enzyme Regul; 1984; 22():325-400. PubMed ID: 6089514
[TBL] [Abstract][Full Text] [Related]
10. PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
Zhang B; Zheng A; Hydbring P; Ambroise G; Ouchida AT; Goiny M; Vakifahmetoglu-Norberg H; Norberg E
Cell Rep; 2017 Jun; 19(11):2289-2303. PubMed ID: 28614715
[TBL] [Abstract][Full Text] [Related]
11. Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy.
Ravez S; Spillier Q; Marteau R; Feron O; Frédérick R
J Med Chem; 2017 Feb; 60(4):1227-1237. PubMed ID: 27959531
[TBL] [Abstract][Full Text] [Related]
12. ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction.
Li X; Gracilla D; Cai L; Zhang M; Yu X; Chen X; Zhang J; Long X; Ding HF; Yan C
Cell Rep; 2021 Sep; 36(12):109706. PubMed ID: 34551291
[TBL] [Abstract][Full Text] [Related]
13. Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
Zhang H; Nabel CS; Li D; O'Connor RÍ; Crosby CR; Chang SM; Hao Y; Stanley R; Sahu S; Levin DS; Chen T; Tang S; Huang HY; Meynardie M; Stephens J; Sherman F; Chafitz A; Costelloe N; Rodrigues DA; Fogarty H; Kiernan MG; Cronin F; Papadopoulos E; Ploszaj M; Weerasekara V; Deng J; Kiely P; Bardeesy N; Vander Heiden MG; Chonghaile TN; Dowling CM; Wong KK
J Thorac Oncol; 2023 Jul; 18(7):882-895. PubMed ID: 36958689
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation.
Li L; Li P; Ma X; Zeng S; Peng Y; Zhang G
Biochem Pharmacol; 2022 Sep; 203():115188. PubMed ID: 35902040
[TBL] [Abstract][Full Text] [Related]
15. p73 regulates serine biosynthesis in cancer.
Amelio I; Markert EK; Rufini A; Antonov AV; Sayan BS; Tucci P; Agostini M; Mineo TC; Levine AJ; Melino G
Oncogene; 2014 Oct; 33(42):5039-46. PubMed ID: 24186203
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.
Liu Y; Marks K; Cowley GS; Carretero J; Liu Q; Nieland TJ; Xu C; Cohoon TJ; Gao P; Zhang Y; Chen Z; Altabef AB; Tchaicha JH; Wang X; Choe S; Driggers EM; Zhang J; Bailey ST; Sharpless NE; Hayes DN; Patel NM; Janne PA; Bardeesy N; Engelman JA; Manning BD; Shaw RJ; Asara JM; Scully R; Kimmelman A; Byers LA; Gibbons DL; Wistuba II; Heymach JV; Kwiatkowski DJ; Kim WY; Kung AL; Gray NS; Root DE; Cantley LC; Wong KK
Cancer Discov; 2013 Aug; 3(8):870-9. PubMed ID: 23715154
[TBL] [Abstract][Full Text] [Related]
17. Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition.
Ngo B; Kim E; Osorio-Vasquez V; Doll S; Bustraan S; Liang RJ; Luengo A; Davidson SM; Ali A; Ferraro GB; Fischer GM; Eskandari R; Kang DS; Ni J; Plasger A; Rajasekhar VK; Kastenhuber ER; Bacha S; Sriram RK; Stein BD; Bakhoum SF; Snuderl M; Cotzia P; Healey JH; Mainolfi N; Suri V; Friedman A; Manfredi M; Sabatini DM; Jones DR; Yu M; Zhao JJ; Jain RK; Keshari KR; Davies MA; Vander Heiden MG; Hernando E; Mann M; Cantley LC; Pacold ME
Cancer Discov; 2020 Sep; 10(9):1352-1373. PubMed ID: 32571778
[TBL] [Abstract][Full Text] [Related]
18. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.
Dai B; Yan S; Lara-Guerra H; Kawashima H; Sakai R; Jayachandran G; Majidi M; Mehran R; Wang J; Bekele BN; Baladandayuthapani V; Yoo SY; Wang Y; Ying J; Meng F; Ji L; Roth JA
PLoS One; 2015; 10(6):e0123967. PubMed ID: 26053020
[TBL] [Abstract][Full Text] [Related]
19. Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer.
Metcalf S; Dougherty S; Kruer T; Hasan N; Biyik-Sit R; Reynolds L; Clem BF
Clin Exp Metastasis; 2020 Feb; 37(1):187-197. PubMed ID: 31630284
[TBL] [Abstract][Full Text] [Related]
20. Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth.
Geeraerts SL; Kampen KR; Rinaldi G; Gupta P; Planque M; Louros N; Heylen E; De Cremer K; De Brucker K; Vereecke S; Verbelen B; Vermeersch P; Schymkowitz J; Rousseau F; Cassiman D; Fendt SM; Voet A; Cammue BPA; Thevissen K; De Keersmaecker K
Mol Cancer Ther; 2021 Jan; 20(1):50-63. PubMed ID: 33203732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
